Margaretha A. Skowron

The pioneer and differentiation factor FOXA2 is a key driver of yolk‐sac tumour formation and a new biomarker for paediatric and adult yolk‐sac tumours

Wasco Wruck, Felix Bremmer, Mara Kotthoff et al. · Journal of Cellular and Molecular Medicine · 2021 · 55 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +17

CDK4/6 inhibition presents as a therapeutic option for paediatric and adult germ cell tumours and induces cell cycle arrest and apoptosis via canonical and non-canonical mechanisms

Margaretha A. Skowron, Marieke Vermeulen, Anna Winkelhausen et al. · British Journal of Cancer · 2020 · 50 citations · Full text

Medicine, Oncology, Pharmacology +15

Targeting urothelial carcinoma cells by combining cisplatin with a specific inhibitor of the autophagy-inducing class III PtdIns3K complex

David Schlütermann, Margaretha A. Skowron, Niklas Berleth et al. · Urologic Oncology Seminars and Original Investigations · 2017 · 49 citations · Full text

Medicine, Oncology, Pharmacology +17

The New Immortalized Uroepithelial Cell Line HBLAK Contains Defined Genetic Aberrations Typical of Early Stage Urothelial Tumors

Michèle J. Hoffmann, Evangelia A. Koutsogiannouli, Margaretha A. Skowron et al. · Bladder Cancer · 2016 · 45 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Multifaceted Mechanisms of Cisplatin Resistance in Long-Term Treated Urothelial Carcinoma Cell Lines

Margaretha A. Skowron, Margarita Melnikova, Joep G.H. van Roermund et al. · International Journal of Molecular Sciences · 2018 · 43 citations · Full text

Medicine, Oncology, Pharmacology +17